Tarik Asselah

Professor Tarik Asselah is a Full Professor of Hepatology at Université Paris Cité and a hepatologist at Hôpital Beaujon, Assistance Publique–Hôpitaux de Paris (AP-HP), in Clichy, France. He heads the Viral Hepatitis research team at INSERM UMR 1149, Centre de Recherche sur l'Inflammation. He holds an MD degree and a PhD in virology.Professor Asselah's research focuses on chronic liver diseases, translational and precision medicine, and the development of innovative treatments for viral hepatitis, particularly hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) infections. He has extensive experience as a coordinator and principal investigator in international clinical trials evaluating novel antiviral therapies for chronic viral hepatitis, with a particular focus on early-phase clinical development, from Phase I to Phase III. His international clinical research leadership includes major trials such as SOLSTICE (NCT05461170; Vir Biotechnology), MYR-204 (NCT03852433; Gilead), OCTOPUS (NCT05275023; Janssen), and ENDURANCE-4 (NCT02636595; AbbVie). In 2023, he contributed his expertise to the European Association for the Study of the Liver (EASL) Clinical Practice Guidelines on hepatitis D.Professor Asselah has authored more than 300 scientific publications in the field of chronic liver diseases, including articles published in leading international journals such as The New England Journal of Medicine, The Lancet, Gastroenterology, Hepatology, and the Journal of Hepatology. His work has received more than 15,000 citations, and his H-index is 65.His scientific contributions and academic leadership have been recognized through several distinctions. In 2005, he received an award from the French Association for the Study of the Liver (AFEF) for his genomic research on HCV. In 2009, he was selected as a Rising Star in Gastroenterology by United European Gastroenterology (UEG), in recognition of his scientific achievements. In 2019, he received an award from the Czech Hepatology Society in recognition of his leadership in hepatology. In 2023, he received the Faculty Outstanding Research Output Award from the Li Ka Shing Faculty of Medicine, The University of Hong Kong. In 2024, he was honored with the Presidential Award of the Asian Pacific Association for the Study of the Liver (APASL) at its annual meeting in Kyoto, Japan.